2025-02-28 |
2025-02-26 |
S
Sale
|
ALEXANDER MARGARET A.
President and COO
Officer
|
5,279
-6.7%
0.56
USD 2,956
|
5,279
-6.7%
|
0.56
|
USD 2,956
|
|
2025-02-28 |
2025-02-26 |
S
Sale
|
Rona Jeffrey A
CBFO
Officer
|
3,902
-5.4%
0.56
USD 2,185
|
3,902
-5.4%
|
0.56
|
USD 2,185
|
|
2025-01-29 |
2025-01-27 |
B
Purchase
|
ALEXANDER MARGARET A.
President and COO
Officer
|
6,810
+24.2%
0.73
USD 4,971
|
6,810
+24.2%
|
0.73
|
USD 4,971
|
|
2024-03-20 |
2024-03-18 |
B
Purchase
|
LEVIN JEREMY M
CEO
Executive Director
|
18,248
+0.5%
2.76
USD 50,364
|
18,248
+0.5%
|
2.76
|
USD 50,364
|
|
2022-09-14 |
2022-09-12 |
PS
Planned sale
|
Tardio Jason
Chief Operating Officer
Officer
|
17,344
-100.0%
2.15
USD 37,290
|
17,344
-100.0%
|
2.15
|
USD 37,290
|
|
2020-09-01 |
2020-08-28 |
B
Purchase
|
LEVIN JEREMY M
CEO
Executive Director
Large shareholder
|
8,488
+0.1%
5.84
USD 49,570
|
8,488
+0.1%
|
5.84
|
USD 49,570
|
|
2019-11-22 |
2019-10-08 |
B
Purchase
|
TAKEDA PHARMACEUTICAL CO LTD
Large shareholder
|
2,000,000
+53.3%
2.50
USD 5,000,000
|
2,000,000
+53.3%
|
2.50
|
USD 5,000,000
|
|
2019-10-10 |
2019-10-08 |
B
Purchase
|
LEVIN JEREMY M
CEO
Executive Director
Large shareholder
|
60,000
+1.3%
2.50
USD 150,000
|
60,000
+1.3%
|
2.50
|
USD 150,000
|
|
2019-02-28 |
2019-02-26 |
B
Purchase
|
Bernstein Karen
Non-Executive Director
|
10,000
+100.0%
2.02
USD 20,210
|
10,000
+100.0%
|
2.02
|
USD 20,210
|
|
2019-02-26 |
2019-02-22 |
B
Purchase
|
LEVIN JEREMY M
CEO
Executive Director
Large shareholder
|
75,000
+1.6%
2.00
USD 150,000
|
75,000
+1.6%
|
2.00
|
USD 150,000
|
|
2018-08-16 |
2018-08-14 |
B
Purchase
|
Bernstein Karen
Non-Executive Director
|
10,000
+inf%
6.23
USD 62,300
|
10,000
+inf%
|
6.23
|
USD 62,300
|
|
2018-08-16 |
2018-08-14 |
B
Purchase
|
WILLIAMS DOUGLAS E
Non-Executive Director
|
5,000
+inf%
6.49
USD 32,442
|
5,000
+inf%
|
6.49
|
USD 32,442
|
|
2017-08-28 |
2017-08-25 |
B
Purchase
|
LEVIN JEREMY M
CEO
Executive Director
Large shareholder
|
15,334
+0.3%
7.15
USD 109,638
|
15,334
+0.3%
|
7.15
|
USD 109,638
|
|